Medical devices

New technology and a changing focus is driving growth in the medtech sector.

The changing focus in healthcare from treatment to prevention and an increased user-centric approach is propelling medtech progress. The rapid uptake of technology using the capabilities of consumer devices and wearables, the application of big data and human-led innovation is fueling the wave of change.

Digital technology has entered all aspects of the industry, whether it is companies that specialise in AI and machine learning, robotics, telehealth and apps, or more traditional companies who must adapt and adopt such technologies to survive and thrive.

Medtech is a marketplace with unique challenges – global multinationals sit side-by-side with SMEs, universities and clinician-led innovation, resulting in a commercial playing field rich in collaboration. IP challenges are categorised by the complications of ownership in multi-party projects and the fast-changing case law around patenting in contentious areas such as medical methods, AI, data handling, software and commercialisation. HGF’s multidisciplinary teams are the ideal support in this evolving and complex sector.

 

Artificial limbs
Medical device

Our medical devices specialists

We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.

HGF’s team has medical devices professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.

Let's talk

If you would like to discuss how HGF could help you, contact one of our medical devices specialists.

Latest news

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

HGF ranked highly recommended in the WIPR Trade Mark Rankings 2025

HGF has been recognised as a leading firm in the recently published World IP Review (WIPR) Trade Mark Rankings 2025. This achievement highlights our continued commitment to excellence in trade …

Read article

T1977/22: Can claims defined by open-ended ranges ever be sufficiently disclosed?

The EPO’s Board of Appeal’s decision in T1977/22 provides an interesting review of the case law concerning the compatibility of whole range sufficiency and claims defined as a result to …

Read article

The draft of The Genetic Technology (Precision Breeding) Regulations 2025 reveals practical details on how to obtain a Precision Bred Organism status

In a recent blog post we discussed the Precision Breeding Regulatory Framework developed by the Food Standards Agency (FSA). Further details on the application process for Precision Bred Organism confirmation …

Read article

A £2.1M Lesson: The Power of Confidential Information

A recent High Court ruling1 serves as a stark reminder of the importance of respecting confidential business information. Hambro Perks, was found guilty of breaching confidentiality and ordered to pay …

Read article
Event - 6th March 2025

IQPC Global IP Exchange Europe 2025

HGF is sponsoring the IQPC Global IP Exchange Europe, which will be held on the 11th-12th March 2025 in Meliá, Berlin. Head of Electronics, Chris Benson, will be chairing the …

Event details

IP Ingredients: Pouring Over the Verdict: What Thatchers v Aldi Means for Food & Drink Brands

Readers of our IP Ingredients blog may recall that we covered something of this case last summer in our post IP Ingredients: Summer case law review. The dispute between Thatchers …

Read article